Breast Biopsy Market Overview
Breast biopsy is a test performed to remove tissue or fluid from a diseased area of the patient’s body, while the removed sample is further examined to check the presence of breast cancer. There are different types of biopsy procedures depending on the product, such as vacuum assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB), recommended by the doctor based on the location, size, and other characteristics of the breast abnormality. The various techniques of biopsy market work quickly and it is simple, results are fast and accurate.
Increase in incidence of breast cancer in women especially around the age of 40 and growth in awareness regarding breast cancer screening programs drive the market growth. Emergence of technologically advanced and minimally invasive breast biopsy devices are expected to provide opportunities in this untapped market. The restraints in this market include high cost of procedure and demand skewed towards specific gender and middle age to elderly age group, eliminating a major chunk of the population segment. The risk of infection due to improper care of breast biopsy cuts and wounds and uncertain regulatory guidelines for medical devices are likely to limit the growth of the market.
Breast Biopsy Market Forecast Report (2018-2023)
Breast Biopsy Market was worth USD 535.75 million in 2018 and estimated to be growing at a CAGR of 10.8%, to reach USD 894.67 million by 2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/breast-biopsy-market-4258/
Breast Biopsy Market Segmentation
Breast Biopsy Market is broadly categorized into product, type and guidance. By product the market is segmented into Biopsy needles, guidance systems, biopsy tables, localization wires and others. By type the market is classified into Needle breast biopsy and open surgical breast biopsy. Vacuum assisted biopsy accounts for a major portion of the revenue. By guidance the market is analyzed under Mammography-Guided Stereotactic Breast Biopsy, Ultrasound-Guided Breast Biopsy, MRI-Guided Breast Biopsy, other techniques. The ultrasound segment is expected to be the fastest growing segment.
On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Breast Biopsy market was dominated by North America followed by Europe. Asia Pacific is expected to grow at the highest CAGR.
The major companies dominating this market for its products and services are
- Hologic Inc.,
- Leica Biosystems Nussloch GmbH
- C. R. Bard, Inc.,
- Becton and Dickinson Company,
- Argon Medical Devices,
- Cook Medical Incorporated,
- Encapsule medical Devices LLC.,
- Ethicon Endo Surgery (Johnson & Johnson),
- Intact Medical Corporation,
- Galini SRL.
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.